Nomura issues ‘Buy’ calls on IndusInd Bank, Voltas, and Sun Pharma with up to 28% upside—read the full analysis to spot your next investment!

The People’s Bank of China held the 1-year loan prime rate at 3.0% and 5-year LPR at 3.5%, according to a statement Friday.

Japanese officials are dismissing alarm over the prediction of a July “catastrophe” in a comic book, “The Future I Saw,” ...

Japan’s finance ministry is considering trimming its issuance of super-long bonds starting in July, according to a draft of a revised bond issuance plan seen by Bloomberg.

Gareth Nicholson of Nomura warns of quake-prone markets driven by tighter spreads, with hedge funds primed to capitalize on ...

Geopolitical instability and ambiguity around tariff impacts are key factors shaping global markets, according to Gareth ...

IndusInd Bank's stock witnessed a significant rise. This followed an upgrade by Nomura from 'Neutral' to 'Buy'. The upgrade ...

Nomura upgrades IndusInd Bank to 'Buy' with a revised target price of Rs 1,050, citing improved governance, cleaned-up books, ...

Find insight on Posco Holdings, Canadian steel and aluminum producers and more in the latest Market Talks covering basic ...

Indirect macro effects from weaker US consumer demand and a strong Taiwan dollar will likely be tempered by sustained AI-led ...

IndusInd Bank's shares rose by nearly 6% after global brokerage firm Nomura upgraded its rating on the stock to buy and increased the target price.

Key Takeaways IndusInd Bank shares surged over 5%, marking their biggest intraday gain since April 15.Nomura maintained a ...